Chloramphenicol + Polymyxin B SulphateThird Party Manufacturing in India

Chloramphenicol + Polymyxin B Sulphate works by combining two distinct, synergistic antibacterial pathways. Chloramphenicol binds reversibly to the 50S ribosomal subunit to block bacterial protein synthesis, while polymyxin B sulphate acts like a surfactant to disrupt the phospholipid structure of the outer membrane in Gram-negative bacteria. Unlike single-antibiotic options, this combination provides exceptional dual action against tough, multi-drug resistant strains. It is highly effective and well-tolerated for superficial eye infections.

Therapeutic Uses

• Bacterial Corneal Ulcers: Treats serious microbial ulcerations affecting the outermost layers of the eye.
• Severe Bacterial Conjunctivitis: Eradicates stubborn bacterial infections of the conjunctiva.
• Prophylaxis in Eye Injuries: Prevents opportunistic bacterial colonization following minor physical eye trauma.

Why Manufacturers Choose Chloramphenicol + Polymyxin B Sulphate

Chloramphenicol + Polymyxin B Sulphate third party manufacturing in India continues to see high demand due to its reliable role as a broad-spectrum emergency treatment for acute eye infections. Our partner production facilities employ modern aseptic filtration technology to ensure these sensitive antibiotic drops remain free from degradation products. This careful processing inside WHO-GMP certified partner plants provides long shelf stability and dependable therapeutic performance.